[Pregnancy and hormone replacement therapy in a patient with resistant ovary syndrome].
We report on the case of a 32-year-old woman with "resistant ovary syndrome". The patient received hormone replacement therapy sequentially with 2 mg estradiol valerate and 2 mg estradiol valerate/0.15 mg levonorgestrel (Klimonorm, Jenapharm, Germany) respectively, because of secondary amenorrhea and premature menopause. Under this therapy she conceived and had a delivery at term following an inconspicuous pregnancy. The case report emphasizes the rare but possible spontaneous remission of "resistant ovary syndrome" as a variant of premature menopause and is discussed in terms of the literature.
Nawroth
F
F
Klinik für Gynäkologie und Geburtshilfe, Klinikum Neubrandenburg. Frank.Nawroth@t-online.de
Sudik
R
R
D000328:Adult; D000568:Amenorrhea / Q000209:etiology; D004338:Drug Combinations; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D016912:Levonorgestrel / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D016649:Primary Ovarian Insufficiency / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
D004338:Drug Combinations; C097275:klimonorm; D004958:Estradiol; D016912:Levonorgestrel
Schwangerschaft unter Hormonersatztherapie bei einer Patientin mit einem passageren "Resistant-Ovary-Syndrome".